España
India
Italia
대한민ęµ
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민ęµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Hims & Hers Health
HIMS
NYSE
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$22.09
0.3
1.38%
Pre-Market: 6:39 AM EDT
Get Report
Comment
Hims & Hers Health (HIMS) Forecast
News
Earnings
Hims & Hers Health (HIMS) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Hims & Hers Health (NYSE:HIMS) Stock
Hims & Hers Health Stock (NYSE: HIMS)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, November 20, 2024
TD Cowen Reiterates Buy on Hims & Hers Health...
Benzinga Newsdesk
Monday, November 18, 2024
Unpacking the Latest Options Trading Trends in Hims & Hers Health
Benzinga Insights
Price Over Earnings Overview: Hims & Hers Health
Benzinga Insights
Friday, November 15, 2024
Hims & Hers Health Insider Trades Send A Signal
Benzinga Insights
Peering Into Hims & Hers Health's Recent Short Interest
Benzinga Insights
Thursday, November 14, 2024
CORRECTION: B of A Securities Downgrades Hims...
Benzinga Newsdesk
Hims & Hers Health Stock Is Tumbling Thursday: What's Going On?
Adam Eckert
Hims & Hers Health shares are trading lower i...
Benzinga Newsdesk
Wednesday, November 13, 2024
What's Going On With Hims & Hers Health Stock On Wednesday?
Vandana Singh
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Tuesday, November 12, 2024
10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
Unpacking the Latest Options Trading Trends in Hims & Hers Health
Benzinga Insights
Monday, November 11, 2024
MARA Holdings, RadNet, Bit Digital, Coinbase And Other Big Stocks Moving Higher On Monday
Avi Kapoor
Friday, November 08, 2024
TD Cowen Maintains Buy on Hims & Hers Health,...
Benzinga Newsdesk
Hims & Hers Health Recent Insider Activity
Benzinga Insights
Thursday, November 07, 2024
Smart Money Is Betting Big In HIMS Options
Benzinga Insights
Wednesday, November 06, 2024
Assessing Hims & Hers Health: Insights From 7 Financial Analysts
Benzinga Insights
Deutsche Bank Maintains Hold on Hims & Hers H...
Benzinga Newsdesk
Tuesday, November 05, 2024
10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
Piper Sandler Reiterates Neutral on Hims & He...
Benzinga Newsdesk
What's Going On With Hims & Hers Health Stock Tuesday?
Vaishali Prayag
Top 10 Trending Stocks On WallStreetBets As O...
Benzinga Newsdesk
Charter Communications To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Tuesday
Avi Kapoor
Canaccord Genuity Maintains Buy on Hims & Her...
Benzinga Newsdesk
Hims & Hers Health shares are trading higher ...
Benzinga Newsdesk
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Palantir, Trump Media, Hims & Hers Health, NXP Semiconductors, And Tesla: Why These 5 Stocks Are On Investors' Radars Today
Benzinga Neuro
Monday, November 04, 2024
Hims & Hers Health shares are trading higher ...
Benzinga Newsdesk
Hims & Hers Health Reports Better-Than-Expected Q3 Results: Details
Erica Kollmann
Hims & Hers Sees Q4 2024 Revenue $465M-$470M
Benzinga Newsdesk
Hims & Hers Raises FY24 Revenue Guidance; See...
Benzinga Newsdesk
Hims & Hers Health Q3 2024 Adj EPS $0.32 Beat...
Benzinga Newsdesk
Decoding Hims & Hers Health's Options Activity: What's the Big Picture?
Benzinga Insights
What's Going On With Hims & Hers Health Stock Monday?
Adam Eckert
Wednesday, October 30, 2024
Hims & Hers Health Stock Is Trading Lower Wednesday: Here's Why
Vaishali Prayag
Hims & Hers Health shares are trading lower i...
Benzinga Newsdesk
Reported Earlier, 'Novo Nordisk's Ozempic and...
Benzinga Newsdesk
Smart Money Is Betting Big In HIMS Options
Benzinga Insights
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Tuesday, October 29, 2024
FDA Inspection Flags Multiple Compliance Issu...
Benzinga Newsdesk
Hims & Hers Reports Outcomes For Weight Loss ...
Benzinga Newsdesk
Monday, October 28, 2024
Google To Launch New "Sexual Health & Wellnes...
Benzinga Newsdesk
Thursday, October 24, 2024
Ozempic And Wegovy Maker Novo Nordisk Asks FDA To Halt Production Of Compounded Fat Loss Drugs Due To Their 'Inherent Complexity'
Shivdeep Dhaliwal
Tuesday, October 22, 2024
Check Out What Whales Are Doing With HIMS
Benzinga Insights
A Look Into Hims & Hers Health Inc's Price Over Earnings
Benzinga Insights
How Is The Market Feeling About Hims & Hers Health?
Benzinga Insights
Monday, October 21, 2024
This Is What Whales Are Betting On Hims & Hers Health
Benzinga Insights
Decoding 6 Analyst Evaluations For Hims & Hers Health
Benzinga Insights
In-Depth Examination Of 6 Analyst Recommendations For Hims & Hers Health
Benzinga Insights
Show More